Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
What ipsilateral lung constraints if any do you utilize for SBRT and or hypofractionated RT in the lungs?
Do you consider mean ipsilateral lung dose?
Related Questions
Would you offer consolidative radiotherapy for oligometastatic NSCLC?
Is moderately hypofractionated RT using 60 Gy/20fx with concurrent chemotherapy appropriate for unresectable stage III NSCLC?
What CTV expansions do you use for NSCLC with conventional chemoradiation and do you do different expansions based on specific histologies?
In a patient with node-positive limited-stage small cell lung cancer, how do you approach radiation in a patient whose small primary tumor resolves after one cycle of chemotherapy?
How do you construct your target volumes for superior sulcus tumors?
Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?
Would you offer SBRT as an alternative to surgery for an atypical carcinoid lung tumor?
Given the findings of SUNSET, demonstrating 60 Gy in 8 fractions to be a safe and effective regimen for ultracentral lesions, in what situations would you elect to use a 10 fraction hypofractionated regimen?
How do you assess whether a patient will be a good DIBH candidate for lung or abdomen treatments?
Is there a role for nintedanib in the management of patients with radiation-induced pulmonary fibrosis?